Nazia Thakur

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 452 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein

Thomas P. Peacock, Jonathan C. Brown, Jie Zhou et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 296 citations · Full text

Life Sciences, Genetics, Infectious Diseases +9

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen et al. · Nature Communications · 2021 · 289 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Steven A. Kemp, Bo Meng, Isabella ATM Ferriera et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 224 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17